The Neuro Experience cover image

Neuroscientist: Why Women Are Being Sold Untested Brain Drugs (The Peptide Lie)

The Neuro Experience

00:00

FDA safety concerns for BPC-157

Louisa explains immunogenicity risks, unknown pharmacokinetics, and the FDA's Category 2 designation.

Play episode from 23:22
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app